Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
MacroGenics
Pharma
TerSera picks up MacroGenics' Margenza for $40M plus milestones
The 2020-approved breast cancer med booked $17.9 million in 2023 sales as it struggled to make a mark in the crowded market.
Zoey Becker
Oct 22, 2024 11:33am
'The Top Line': The SVB failure, plus this week's headlines
Mar 17, 2023 6:00am
MacroGenics' Margenza fails to extend life over Herceptin
Sep 8, 2021 10:10am
Daiichi-AZ, Celltrion, Zai—Fierce Pharma Asia
Jun 18, 2021 9:58am
MacroGenics wins breast cancer nod with Herceptin-topping data
Dec 17, 2020 11:53am
